Literature DB >> 3005396

IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.

D S Taylor, J A Kern, P C Nowell.   

Abstract

To investigate the ability of interleukin 2 (IL 2) alone to induce proliferation of resting human lymphocytes, we stimulated human peripheral blood mononuclear cells (PBMC) with an immunopurified preparation of IL 2 or with phytohemagglutinin (PHA). Proliferation and the percent of cells expressing IL 2 receptors were assessed over 6 days of culture. Regardless of the stimulus, the percent of cells bearing an IL 2 receptor paralleled the amount of proliferation, and proliferation was inhibited by an anti-IL 2 receptor monoclonal antibody (anti-Tac). When stimulated by IL 2 alone, less than 8% of PBMC expressed an IL 2 receptor after 24 hr of culture. Stimulation by IL 2 caused both proliferation and IL 2 receptor expression to increase over the entire culture period (routinely to 75,000 cpm and 50% respectively). When colchicine was added (to inhibit cell division), the percent of cells bearing an IL 2 receptor did not increase. IL 2 alone also induced proliferation of PBMC depleted of accessory cells, with the same kinetics but reduced peak response. Both accessory cells and supernatants that showed IL 1 but not IL 2 activity augmented this proliferation 50 to 100%. In contrast to the effect of IL 2, 25 to 50% of PBMC stimulated by PHA expressed an IL 2 receptor after 24 hr of culture. PHA-induced proliferation and IL 2 receptor expression peaked early in the culture period (routinely to 100,000 cpm and 50% respectively within 3 days), and colchicine did not inhibit the early induction of IL 2 receptors on PBMC. Our findings indicate that unlike PHA, IL 2 induces proliferation of PBMC (or PBMC depleted of accessory cells) by expanding the small percentage of cells in a resting population that already express IL 2 receptors. IL 2 does not appear to induce IL 2 receptors on cells previously lacking this molecule. We also find that IL 1 can enhance the response to IL 2 alone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005396

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes.

Authors:  S L King
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

2.  Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation.

Authors:  D S Taylor; P C Nowell; J Kornbluth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides.

Authors:  N Tvede; C Heilmann; L D Christensen
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine-activated killer cells.

Authors:  J D Gray; D A Horwitz
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

5.  IL-2-induced polyclonal proliferation of human peripheral blood lymphocytes: functional and phenotypic characteristics of proliferating cells.

Authors:  B K Mookerjee; P B Chen; J L Pauly
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

6.  Interleukin-2-induced lymphoproliferative responses.

Authors:  A Winkelstein; L D Weaver; N Salva; L L Machen
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Immune and hormonal changes in early-stage chronic lymphocytic leukemia patients.

Authors:  H Everaus; J Lehtmaa; E Luik; H Kŏdar
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

8.  Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotype.

Authors:  U Testa; A Care; E Montesoro; C Fossati; G Giannella; R Masciulli; M Fagioli; D Bulgarini; D Habetswallner; G Isacchi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Proliferation assay amplification by IL-2 in model primary and recall antigen systems.

Authors:  Amy S M Kennell; Keith G Gould; Myer R Salaman
Journal:  BMC Res Notes       Date:  2014-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.